| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.952 | 0.002 | 0.952 | Aldehyde oxidase inhibitor | 0.749 0.005 CHEMBL1450936 0.519 0.03 CHEMBL3544861 | ||
| 0.945 | 0.002 | 0.945 | Estrogen antagonist | 0.802 0.003 CHEMBL1450936 0.531 0.004 CHEMBL3544861 | ||
| 0.873 | 0.002 | 0.952 | Estrogen agonist | 0.952 0.001 CHEMBL1450936 0.546 0.003 CHEMBL3544861 | CHEMBL1450936 | |
| 0.867 | 0.002 | 0.867 | Estrogen receptor beta antagonist | 0.774 0.002 CHEMBL1450936 0.286 0.005 CHEMBL3544861 | ||
| 0.799 | 0.011 | 0.799 | Caspase 9 stimulant | 0.646 0.03 CHEMBL1450936 0.799 0.011 CHEMBL3544861 | ||
| 0.696 | 0.007 | 0.696 | 5 Hydroxytryptamine release stimulant | 0.658 0.01 CHEMBL1450936 0.552 0.02 CHEMBL3544861 | ||
| 0.68 | 0.003 | 0.68 | Alcohol oxidase inhibitor | 0.446 0.004 CHEMBL1450936 0.095 0.019 CHEMBL3544861 | ||
| 0.625 | 0.005 | 0.625 | P-glycoprotein inhibitor | 0.181 0.079 CHEMBL1450936 0.416 0.014 CHEMBL3544861 | ||
| 0.625 | 0.005 | 0.625 | GABA C receptor rho-3 antagonist | 0.611 0.006 CHEMBL1450936 | ||
| 0.605 | 0.004 | 0.605 | Peroxidase inhibitor | 0.561 0.005 CHEMBL1450936 | ||
| 0.603 | 0.006 | 0.603 | Vasodilator | 0.181 0.121 CHEMBL1450936 0.574 0.007 CHEMBL3544861 | ||
| 0.561 | 0.003 | 0.581 | Tyrosine 3 hydroxylase inhibitor | 0.581 0.003 CHEMBL1450936 | CHEMBL1450936 | |
| 0.562 | 0.017 | 0.638 | 5 Hydroxytryptamine release inhibitor | 0.471 0.043 CHEMBL1450936 0.638 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.541 | 0.033 | 0.541 | 15-Lipoxygenase inhibitor | 0.305 0.129 CHEMBL1450936 | ||
| 0.505 | 0.002 | 0.505 | Estrogen receptor alpha agonist | 0.184 0.005 CHEMBL1450936 0.122 0.006 CHEMBL3544861 | ||
| 0.502 | 0.003 | 0.502 | Estrogen receptor beta agonist | 0.179 0.005 CHEMBL1450936 0.198 0.005 CHEMBL3544861 | ||
| 0.508 | 0.014 | 0.76 | Vasodilator, coronary | 0.36 0.05 CHEMBL1450936 0.76 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.487 | 0.005 | 0.487 | 5 Hydroxytryptamine uptake stimulant | 0.404 0.014 CHEMBL1450936 0.209 0.135 CHEMBL3544861 | ||
| 0.486 | 0.014 | 0.486 | Superoxide dismutase inhibitor | 0.459 0.018 CHEMBL1450936 | ||
| 0.5 | 0.033 | 0.71 | Cholesterol antagonist | 0.405 0.048 CHEMBL1450936 0.71 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.529 | 0.066 | 0.689 | Apoptosis agonist | 0.475 0.082 CHEMBL1450936 0.689 0.033 CHEMBL3544861 | CHEMBL3544861 | |
| 0.49 | 0.032 | 0.617 | Histamine release inhibitor | 0.438 0.056 CHEMBL1450936 0.617 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.442 | 0.005 | 0.442 | Cyclooxygenase 1 inhibitor | 0.176 0.045 CHEMBL1450936 0.236 0.024 CHEMBL3544861 | ||
| 0.471 | 0.04 | 0.471 | Calcium channel L-type activator | 0.446 0.053 CHEMBL1450936 0.24 0.217 CHEMBL3544861 | ||
| 0.44 | 0.032 | 0.44 | Caspase 3 stimulant | 0.246 0.115 CHEMBL1450936 0.432 0.035 CHEMBL3544861 | ||
| 0.452 | 0.046 | 0.567 | Immunosuppressant | 0.259 0.141 CHEMBL1450936 0.567 0.018 CHEMBL3544861 | CHEMBL3544861 | |
| 0.429 | 0.024 | 0.515 | Hypoxia-inducible factor 1 alpha inhibitor | 0.261 0.09 CHEMBL1450936 0.515 0.013 CHEMBL3544861 | CHEMBL3544861 | |
| 0.434 | 0.029 | 0.434 | Lipoxygenase inhibitor | 0.287 0.078 CHEMBL1450936 | ||
| 0.41 | 0.008 | 0.545 | Alpha-N-acetylglucosaminidase inhibitor | 0.427 0.008 CHEMBL1450936 0.545 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.419 | 0.026 | 0.661 | Free radical scavenger | 0.522 0.014 CHEMBL1450936 0.661 0.006 CHEMBL3544861 | CHEMBL3544861 | |
| 0.381 | 0.003 | 0.381 | Creatine kinase inhibitor | 0.297 0.004 CHEMBL1450936 0.116 0.044 CHEMBL3544861 | ||
| 0.377 | 0.004 | 0.377 | Estrogen receptor alpha antagonist | 0.353 0.004 CHEMBL1450936 0.072 0.064 CHEMBL3544861 | ||
| 0.398 | 0.035 | 0.702 | Antioxidant | 0.433 0.029 CHEMBL1450936 0.702 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.373 | 0.02 | 0.373 | Anesthetic general | 0.351 0.024 CHEMBL1450936 0.35 0.024 CHEMBL3544861 | ||
| 0.342 | 0.006 | 0.342 | Succinate dehydrogenase inhibitor | 0.306 0.01 CHEMBL1450936 0.181 0.067 CHEMBL3544861 | ||
| 0.36 | 0.034 | 0.383 | Sodium/bile acid cotransporter inhibitor | 0.383 0.023 CHEMBL1450936 0.297 0.082 CHEMBL3544861 | CHEMBL1450936 | |
| 0.381 | 0.055 | 0.628 | Immunostimulant | 0.249 0.097 CHEMBL1450936 0.628 0.014 CHEMBL3544861 | CHEMBL3544861 | |
| 0.332 | 0.011 | 0.376 | Neurotrophic factor enhancer | 0.29 0.021 CHEMBL1450936 0.376 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.323 | 0.014 | 0.323 | Cyclooxygenase inhibitor | 0.137 0.081 CHEMBL1450936 0.193 0.045 CHEMBL3544861 | ||
| 0.313 | 0.005 | 0.313 | Porphobilinogen synthase inhibitor | 0.268 0.006 CHEMBL1450936 | ||
| 0.36 | 0.053 | 0.36 | 12-Lipoxygenase inhibitor | 0.337 0.062 CHEMBL1450936 | ||
| 0.353 | 0.048 | 0.353 | Calcium channel activator | 0.332 0.063 CHEMBL1450936 | ||
| 0.309 | 0.013 | 0.309 | Growth factor agonist | 0.171 0.1 CHEMBL3544861 | ||
| 0.302 | 0.007 | 0.302 | Ferrochelatase inhibitor | 0.222 0.018 CHEMBL1450936 | ||
| 0.361 | 0.073 | 0.718 | Transcription factor NF kappa B inhibitor | 0.425 0.058 CHEMBL1450936 0.718 0.019 CHEMBL3544861 | CHEMBL3544861 | |
| 0.293 | 0.01 | 0.298 | GABA C receptor agonist | 0.298 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.285 | 0.011 | 0.307 | Cystathionine beta-synthase inhibitor | 0.307 0.009 CHEMBL1450936 0.283 0.011 CHEMBL3544861 | CHEMBL1450936 | |
| 0.292 | 0.019 | 0.292 | Phospholipase C inhibitor | 0.222 0.033 CHEMBL1450936 0.244 0.026 CHEMBL3544861 | ||
| 0.386 | 0.113 | 0.386 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.38 0.119 CHEMBL1450936 | ||
| 0.291 | 0.023 | 0.538 | Melanin inhibitor | 0.33 0.018 CHEMBL1450936 0.538 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.292 | 0.026 | 0.292 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.274 0.032 CHEMBL1450936 0.231 0.052 CHEMBL3544861 | ||
| 0.28 | 0.014 | 0.284 | Aldehyde dehydrogenase inhibitor | 0.226 0.022 CHEMBL1450936 0.284 0.013 CHEMBL3544861 | CHEMBL3544861 | |
| 0.276 | 0.019 | 0.284 | Nitric-oxide synthase stimulant | 0.278 0.018 CHEMBL1450936 0.284 0.016 CHEMBL3544861 | CHEMBL3544861 | |
| 0.25 | 0.006 | 0.25 | GABA C receptor antagonist | 0.21 0.011 CHEMBL1450936 | ||
| 0.292 | 0.052 | 0.419 | Interleukin agonist | 0.31 0.043 CHEMBL1450936 0.419 0.016 CHEMBL3544861 | CHEMBL3544861 | |
| 0.251 | 0.011 | 0.251 | GABA C receptor rho-2 antagonist | 0.245 0.013 CHEMBL1450936 | ||
| 0.261 | 0.024 | 0.462 | Protein kinase stimulant | 0.341 0.013 CHEMBL1450936 0.462 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.322 | 0.086 | 0.322 | Vasodilator, peripheral | 0.256 0.123 CHEMBL1450936 0.277 0.109 CHEMBL3544861 | ||
| 0.297 | 0.061 | 0.297 | Insulysin inhibitor | 0.283 0.07 CHEMBL1450936 | ||
| 0.237 | 0.002 | 0.237 | Estrogen-related receptor beta agonist | 0.168 0.003 CHEMBL1450936 0.095 0.032 CHEMBL3544861 | ||
| 0.255 | 0.024 | 0.255 | Acetylcholine M1 receptor antagonist | 0.116 0.115 CHEMBL1450936 | ||
| 0.267 | 0.041 | 0.267 | RNA-directed DNA polymerase inhibitor | 0.253 0.048 CHEMBL1450936 0.229 0.065 CHEMBL3544861 | ||
| 0.231 | 0.008 | 0.231 | Opioid kappa receptor antagonist | 0.079 0.06 CHEMBL1450936 | ||
| 0.228 | 0.005 | 0.228 | Prolactin inhibitor | 0.19 0.01 CHEMBL1450936 | ||
| 0.229 | 0.006 | 0.233 | Keratolytic | 0.233 0.006 CHEMBL1450936 | CHEMBL1450936 | |
| 0.298 | 0.075 | 0.465 | Interleukin 2 agonist | 0.408 0.025 CHEMBL1450936 0.465 0.013 CHEMBL3544861 | CHEMBL3544861 | |
| 0.236 | 0.014 | 0.415 | UDP-glucose 4-epimerase inhibitor | 0.251 0.013 CHEMBL1450936 0.415 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.247 | 0.029 | 0.603 | Amylase inhibitor | 0.258 0.026 CHEMBL1450936 0.603 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.23 | 0.012 | 0.243 | Arachidonic acid antagonist | 0.243 0.007 CHEMBL1450936 0.172 0.063 CHEMBL3544861 | CHEMBL1450936 | |
| 0.279 | 0.066 | 0.319 | DNA damaging | 0.211 0.107 CHEMBL1450936 0.319 0.05 CHEMBL3544861 | CHEMBL3544861 | |
| 0.223 | 0.011 | 0.223 | Androgen antagonist | 0.105 0.043 CHEMBL1450936 | ||
| 0.264 | 0.053 | 0.271 | Psychostimulant | 0.216 0.072 CHEMBL1450936 0.271 0.051 CHEMBL3544861 | CHEMBL3544861 | |
| 0.217 | 0.007 | 0.217 | Pregnane X receptor agonist | 0.154 0.047 CHEMBL1450936 | ||
| 0.223 | 0.015 | 0.223 | Toll-Like receptor 2 antagonist | 0.192 0.027 CHEMBL1450936 0.112 0.087 CHEMBL3544861 | ||
| 0.239 | 0.031 | 0.424 | Interferon gamma antagonist | 0.254 0.028 CHEMBL1450936 0.424 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.212 | 0.005 | 0.212 | DOPA decarboxylase inhibitor | 0.197 0.007 CHEMBL1450936 | ||
| 0.275 | 0.07 | 0.336 | Transcription factor STAT inhibitor | 0.336 0.039 CHEMBL1450936 | CHEMBL1450936 | |
| 0.21 | 0.006 | 0.21 | Phenylalanine 4-hydroxylase inhibitor | 0.193 0.007 CHEMBL1450936 | ||
| 0.271 | 0.069 | 0.323 | Transcription factor STAT3 inhibitor | 0.323 0.043 CHEMBL1450936 | CHEMBL1450936 | |
| 0.208 | 0.006 | 0.208 | Glutamate decarboxylase inhibitor | 0.19 0.008 CHEMBL1450936 | ||
| 0.21 | 0.009 | 0.228 | TRPA1 agonist | 0.228 0.007 CHEMBL1450936 0.152 0.03 CHEMBL3544861 | CHEMBL1450936 | |
| 0.28 | 0.078 | 0.415 | Spasmolytic | 0.266 0.085 CHEMBL1450936 0.415 0.037 CHEMBL3544861 | CHEMBL3544861 | |
| 0.214 | 0.014 | 0.214 | Carbonic anhydrase III inhibitor | 0.189 0.018 CHEMBL1450936 0.141 0.032 CHEMBL3544861 | ||
| 0.201 | 0.001 | 0.201 | Estrogen-related receptor beta antagonist | 0.136 0.002 CHEMBL1450936 0.056 0.004 CHEMBL3544861 | ||
| 0.214 | 0.015 | 0.214 | CF transmembrane conductance regulator agonist | 0.19 0.028 CHEMBL1450936 0.172 0.044 CHEMBL3544861 | ||
| 0.208 | 0.01 | 0.208 | Adenylate cyclase stimulant | 0.201 0.013 CHEMBL1450936 0.154 0.056 CHEMBL3544861 | ||
| 0.208 | 0.012 | 0.216 | Histidine decarboxylase inhibitor | 0.216 0.011 CHEMBL1450936 | CHEMBL1450936 | |
| 0.264 | 0.069 | 0.707 | Hypoglycemic | 0.229 0.09 CHEMBL1450936 0.707 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.236 | 0.043 | 0.237 | Insulin sensitizer | 0.237 0.042 CHEMBL1450936 0.23 0.047 CHEMBL3544861 | CHEMBL1450936 | |
| 0.201 | 0.008 | 0.201 | Thioredoxin inhibitor | 0.105 0.043 CHEMBL1450936 0.199 0.008 CHEMBL3544861 | ||
| 0.195 | 0.004 | 0.198 | Ca2+-transporting ATPase inhibitor | 0.198 0.004 CHEMBL1450936 0.185 0.005 CHEMBL3544861 | CHEMBL1450936 | |
| 0.254 | 0.064 | 0.407 | DNA synthesis inhibitor | 0.277 0.052 CHEMBL1450936 0.407 0.021 CHEMBL3544861 | CHEMBL3544861 | |
| 0.249 | 0.062 | 0.275 | Pyruvate kinase inhibitor | 0.275 0.054 CHEMBL1450936 | CHEMBL1450936 | |
| 0.198 | 0.011 | 0.332 | Triose-phosphate isomerase inhibitor | 0.179 0.014 CHEMBL1450936 0.332 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.195 | 0.009 | 0.195 | GABA C receptor rho-1 antagonist | 0.176 0.013 CHEMBL1450936 | ||
| 0.215 | 0.03 | 0.561 | Monophenol monooxygenase inhibitor | 0.228 0.027 CHEMBL1450936 0.561 0.006 CHEMBL3544861 | CHEMBL3544861 | |
| 0.202 | 0.018 | 0.202 | Carbonic anhydrase XV inhibitor | 0.176 0.023 CHEMBL1450936 | ||
| 0.195 | 0.012 | 0.195 | Opioid delta receptor antagonist | 0.078 0.037 CHEMBL1450936 | ||
| 0.212 | 0.03 | 0.212 | Neurotensin receptor agonist | 0.184 0.046 CHEMBL1450936 | ||
| 0.202 | 0.023 | 0.202 | Alpha 2b adrenoreceptor antagonist | |||
| 0.189 | 0.011 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.159 0.031 CHEMBL1450936 | ||
| 0.182 | 0.007 | 0.182 | Anabolic | 0.162 0.012 CHEMBL1450936 0.135 0.027 CHEMBL3544861 | ||
| 0.188 | 0.015 | 0.211 | Breast cancer-resistant protein inhibitor | 0.211 0.013 CHEMBL1450936 | CHEMBL1450936 | |
| 0.248 | 0.077 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.236 0.09 CHEMBL1450936 | ||
| 0.265 | 0.094 | 0.265 | Streptokinase A inhibitor | |||
| 0.291 | 0.12 | 0.291 | Calpain 2 inhibitor | |||
| 0.197 | 0.027 | 0.197 | Cholesterol synthesis inhibitor | 0.168 0.036 CHEMBL1450936 0.152 0.044 CHEMBL3544861 | ||
| 0.186 | 0.017 | 0.186 | Adenylate kinase inhibitor | 0.18 0.018 CHEMBL1450936 0.123 0.041 CHEMBL3544861 | ||
| 0.173 | 0.007 | 0.173 | Ornithine decarboxylase inhibitor | 0.132 0.018 CHEMBL1450936 0.14 0.014 CHEMBL3544861 | ||
| 0.204 | 0.04 | 0.228 | Phospholipase A2 inhibitor | 0.228 0.03 CHEMBL1450936 0.179 0.055 CHEMBL3544861 | CHEMBL1450936 | |
| 0.23 | 0.067 | 0.421 | Peptidyltransferase inhibitor | 0.208 0.089 CHEMBL1450936 0.421 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.187 | 0.024 | 0.525 | Cyclooxygenase 3 inhibitor | 0.167 0.035 CHEMBL1450936 0.525 0.003 CHEMBL3544861 | CHEMBL3544861 | |
| 0.165 | 0.002 | 0.165 | Dopamine D5 agonist | 0.115 0.004 CHEMBL1450936 | ||
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.156 0.052 CHEMBL1450936 | ||
| 0.179 | 0.018 | 0.179 | Opioid antagonist | 0.085 0.062 CHEMBL1450936 | ||
| 0.181 | 0.024 | 0.181 | MAP kinase kinase 4 inhibitor | 0.165 0.039 CHEMBL1450936 | ||
| 0.177 | 0.02 | 0.203 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.161 0.024 CHEMBL1450936 0.203 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.17 | 0.014 | 0.17 | Opioid mu receptor antagonist | 0.067 0.048 CHEMBL1450936 | ||
| 0.171 | 0.015 | 0.273 | Phosphofructokinase-1 inhibitor | 0.15 0.018 CHEMBL1450936 0.273 0.006 CHEMBL3544861 | CHEMBL3544861 | |
| 0.175 | 0.019 | 0.263 | Photosensitizer | 0.14 0.038 CHEMBL1450936 0.263 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.182 | 0.026 | 0.182 | Aminopeptidase B inhibitor | 0.151 0.037 CHEMBL1450936 | ||
| 0.215 | 0.06 | 0.453 | Non-steroidal antiinflammatory agent | 0.224 0.055 CHEMBL1450936 0.453 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.173 | 0.018 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.171 0.019 CHEMBL1450936 | ||
| 0.175 | 0.021 | 0.18 | Vanilloid 1 agonist | 0.18 0.018 CHEMBL1450936 0.164 0.027 CHEMBL3544861 | CHEMBL1450936 | |
| 0.166 | 0.013 | 0.166 | Dopamine D1 antagonist | |||
| 0.159 | 0.007 | 0.159 | Androgen agonist | 0.091 0.018 CHEMBL1450936 0.053 0.052 CHEMBL3544861 | ||
| 0.164 | 0.015 | 0.29 | NADH dehydrogenase inhibitor | 0.17 0.014 CHEMBL1450936 0.29 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.193 | 0.044 | 0.358 | Lipid peroxidase inhibitor | 0.199 0.042 CHEMBL1450936 0.358 0.012 CHEMBL3544861 | CHEMBL3544861 | |
| 0.168 | 0.022 | 0.168 | Catalase inhibitor | 0.119 0.033 CHEMBL1450936 | ||
| 0.155 | 0.01 | 0.16 | Lanosterol 14 alpha demethylase inhibitor | 0.16 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.175 | 0.032 | 0.212 | Interleukin 4 antagonist | 0.212 0.019 CHEMBL1450936 0.176 0.031 CHEMBL3544861 | CHEMBL1450936 | |
| 0.261 | 0.118 | 0.676 | Antithrombotic | 0.24 0.135 CHEMBL1450936 0.676 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.221 | 0.08 | 0.368 | Cyclic AMP phosphodiesterase inhibitor | 0.218 0.081 CHEMBL1450936 0.368 0.022 CHEMBL3544861 | CHEMBL3544861 | |
| 0.201 | 0.061 | 0.213 | 5 Hydroxytryptamine 3E antagonist | 0.213 0.044 CHEMBL1450936 | CHEMBL1450936 | |
| 0.224 | 0.084 | 0.232 | Neuropeptide Y2 antagonist | 0.232 0.074 CHEMBL1450936 | CHEMBL1450936 | |
| 0.158 | 0.018 | 0.158 | Alcohol dehydrogenase inhibitor | 0.119 0.036 CHEMBL1450936 0.145 0.022 CHEMBL3544861 | ||
| 0.144 | 0.005 | 0.144 | Plasminogen activator inhibitor antagonist | 0.061 0.023 CHEMBL1450936 | ||
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | 0.213 0.13 CHEMBL1450936 | ||
| 0.183 | 0.047 | 0.345 | Hexokinase inhibitor | 0.182 0.048 CHEMBL1450936 0.345 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.142 | 0.007 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | 0.124 0.013 CHEMBL1450936 | ||
| 0.151 | 0.016 | 0.151 | CYP2A6 inhibitor | 0.135 0.021 CHEMBL1450936 | ||
| 0.162 | 0.027 | 0.162 | Alpha 2c adrenoreceptor antagonist | |||
| 0.161 | 0.027 | 0.174 | Heat shock protein 70 antagonist | 0.163 0.024 CHEMBL1450936 0.174 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.17 | 0.036 | 0.17 | Proteasome inhibitor | 0.136 0.055 CHEMBL1450936 | ||
| 0.19 | 0.057 | 0.389 | Thrombolytic | 0.389 0.012 CHEMBL3544861 | CHEMBL3544861 | |
| 0.164 | 0.033 | 0.181 | 5-Lipoxygenase inhibitor | 0.181 0.029 CHEMBL1450936 | CHEMBL1450936 | |
| 0.14 | 0.01 | 0.14 | GABA aminotransferase inhibitor | 0.13 0.012 CHEMBL1450936 0.138 0.01 CHEMBL3544861 | ||
| 0.174 | 0.044 | 0.174 | Bone formation stimulant | 0.147 0.062 CHEMBL3544861 | ||
| 0.157 | 0.028 | 0.169 | Papain-like protease (SARS coronavirus) inhibitor | 0.169 0.021 CHEMBL1450936 | CHEMBL1450936 | |
| 0.169 | 0.041 | 0.169 | Anesthetic local | 0.142 0.053 CHEMBL1450936 | ||
| 0.164 | 0.037 | 0.164 | Cathepsin H inhibitor | 0.143 0.052 CHEMBL1450936 | ||
| 0.156 | 0.029 | 0.167 | Mucolytic | 0.147 0.034 CHEMBL1450936 0.167 0.024 CHEMBL3544861 | CHEMBL3544861 | |
| 0.133 | 0.008 | 0.133 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 CHEMBL1450936 | ||
| 0.136 | 0.012 | 0.136 | Leukotriene antagonist | 0.067 0.043 CHEMBL1450936 0.125 0.014 CHEMBL3544861 | ||
| 0.143 | 0.019 | 0.143 | ABCA1 expression enhancer | |||
| 0.137 | 0.013 | 0.137 | Argininosuccinate synthase inhibitor | 0.088 0.023 CHEMBL1450936 0.069 0.031 CHEMBL3544861 | ||
| 0.14 | 0.018 | 0.14 | Glutamate dehydrogenase inhibitor | 0.134 0.019 CHEMBL1450936 0.085 0.04 CHEMBL3544861 | ||
| 0.218 | 0.097 | 0.218 | Calpain inhibitor | |||
| 0.135 | 0.015 | 0.144 | Aromatase inhibitor | 0.144 0.014 CHEMBL1450936 | CHEMBL1450936 | |
| 0.165 | 0.045 | 0.165 | Cyclooxygenase 2 inhibitor | 0.109 0.093 CHEMBL1450936 0.112 0.089 CHEMBL3544861 | ||
| 0.13 | 0.01 | 0.13 | D-Ala-D-Ala ligase inhibitor | 0.13 0.01 CHEMBL1450936 | ||
| 0.177 | 0.058 | 0.273 | Interleukin 6 antagonist | 0.177 0.058 CHEMBL1450936 0.273 0.019 CHEMBL3544861 | CHEMBL3544861 | |
| 0.145 | 0.027 | 0.149 | Transcription factor STAT6 inhibitor | 0.149 0.024 CHEMBL1450936 | CHEMBL1450936 | |
| 0.158 | 0.039 | 0.158 | Acetylcholine muscarinic antagonist | |||
| 0.184 | 0.066 | 0.184 | Growth hormone agonist | |||
| 0.128 | 0.01 | 0.15 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.15 0.007 CHEMBL1450936 0.149 0.007 CHEMBL3544861 | CHEMBL1450936 | |
| 0.128 | 0.01 | 0.128 | Purinergic P2X1 antagonist | 0.108 0.014 CHEMBL1450936 0.063 0.039 CHEMBL3544861 | ||
| 0.178 | 0.06 | 0.307 | ATPase inhibitor | 0.208 0.031 CHEMBL1450936 0.307 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.119 | 0.002 | 0.119 | Estrogen-related receptor gamma agonist | 0.032 0.004 CHEMBL1450936 | ||
| 0.14 | 0.023 | 0.14 | Electrolyte absorption antagonist | 0.114 0.042 CHEMBL1450936 | ||
| 0.14 | 0.023 | 0.14 | Carbonic anhydrase VI inhibitor | 0.135 0.024 CHEMBL1450936 0.077 0.061 CHEMBL3544861 | ||
| 0.128 | 0.011 | 0.14 | Acyl-CoA dehydrogenase inhibitor | 0.14 0.01 CHEMBL1450936 0.051 0.042 CHEMBL3544861 | CHEMBL1450936 | |
| 0.134 | 0.02 | 0.134 | Macrophage migration inhibitory factor inhibitor | 0.117 0.027 CHEMBL1450936 | ||
| 0.128 | 0.016 | 0.128 | Beta tubulin antagonist | 0.105 0.021 CHEMBL1450936 | ||
| 0.123 | 0.012 | 0.123 | Glycine receptor agonist | 0.106 0.018 CHEMBL1450936 0.102 0.02 CHEMBL3544861 | ||
| 0.114 | 0.003 | 0.114 | Pregnane X receptor antagonist | 0.084 0.005 CHEMBL1450936 0.055 0.046 CHEMBL3544861 | ||
| 0.157 | 0.046 | 0.185 | DNA polymerase I inhibitor | 0.104 0.082 CHEMBL1450936 0.185 0.033 CHEMBL3544861 | CHEMBL3544861 | |
| 0.119 | 0.009 | 0.119 | CC chemokine 5 receptor agonist | 0.106 0.016 CHEMBL1450936 | ||
| 0.127 | 0.018 | 0.127 | Aminopeptidase I inhibitor | 0.11 0.023 CHEMBL1450936 | ||
| 0.127 | 0.018 | 0.127 | Glutamate release inhibitor | 0.103 0.038 CHEMBL1450936 0.125 0.019 CHEMBL3544861 | ||
| 0.183 | 0.075 | 0.465 | Nitric oxide antagonist | 0.351 0.032 CHEMBL1450936 0.465 0.019 CHEMBL3544861 | CHEMBL3544861 | |
| 0.117 | 0.008 | 0.117 | GABA B receptor agonist | 0.098 0.018 CHEMBL1450936 | ||
| 0.116 | 0.008 | 0.116 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.106 0.009 CHEMBL1450936 | ||
| 0.268 | 0.16 | 0.644 | Antibacterial | 0.38 0.086 CHEMBL1450936 0.644 0.014 CHEMBL3544861 | CHEMBL3544861 | |
| 0.145 | 0.038 | 0.145 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.075 CHEMBL1450936 | ||
| 0.115 | 0.008 | 0.115 | Phospholipase D inhibitor | 0.084 0.029 CHEMBL1450936 | ||
| 0.126 | 0.019 | 0.126 | Glutathione S-transferase inhibitor | 0.109 0.03 CHEMBL1450936 | ||
| 0.137 | 0.03 | 0.137 | Sphingomyelinase inhibitor | 0.109 0.051 CHEMBL1450936 0.101 0.058 CHEMBL3544861 | ||
| 0.154 | 0.048 | 0.154 | Farnesoid X receptor antagonist | 0.134 0.076 CHEMBL1450936 | ||
| 0.161 | 0.055 | 0.173 | Mannose-6-phosphate isomerase inhibitor | 0.173 0.047 CHEMBL1450936 0.158 0.058 CHEMBL3544861 | CHEMBL1450936 | |
| 0.161 | 0.056 | 0.345 | Cell wall synthesis inhibitor | 0.18 0.04 CHEMBL1450936 0.345 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.127 | 0.026 | 0.138 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.138 0.023 CHEMBL1450936 | CHEMBL1450936 | |
| 0.128 | 0.027 | 0.128 | Alpha 2a adrenoreceptor antagonist | |||
| 0.14 | 0.04 | 0.424 | Expectorant | 0.162 0.031 CHEMBL1450936 0.424 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.132 | 0.033 | 0.132 | Electron transport complex I inhibitor | 0.131 0.035 CHEMBL1450936 | ||
| 0.113 | 0.015 | 0.113 | Biliverdin reductase inhibitor | 0.107 0.016 CHEMBL1450936 0.057 0.043 CHEMBL3544861 | ||
| 0.115 | 0.017 | 0.115 | Carbamoyl phosphate synthetase inhibitor | 0.093 0.023 CHEMBL1450936 | ||
| 0.164 | 0.066 | 0.203 | Protein-tyrosine phosphatase inhibitor | 0.203 0.045 CHEMBL1450936 0.175 0.059 CHEMBL3544861 | CHEMBL1450936 | |
| 0.105 | 0.009 | 0.106 | MAP kinase kinase 7 inhibitor | 0.106 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.12 | 0.027 | 0.12 | Phosphodiesterase I inhibitor | |||
| 0.113 | 0.022 | 0.149 | Glycine receptor antagonist | 0.09 0.042 CHEMBL1450936 0.149 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.111 | 0.021 | 0.111 | Adenosine A3 receptor antagonist | |||
| 0.119 | 0.03 | 0.154 | Carbonic anhydrase XIII inhibitor | 0.114 0.032 CHEMBL1450936 0.154 0.021 CHEMBL3544861 | CHEMBL3544861 | |
| 0.134 | 0.045 | 0.134 | 5 Hydroxytryptamine 3A agonist | 0.111 0.064 CHEMBL1450936 | ||
| 0.097 | 0.009 | 0.097 | Aconitate hydratase inhibitor | 0.095 0.009 CHEMBL1450936 | ||
| 0.164 | 0.077 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.141 0.129 CHEMBL1450936 | ||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | 0.085 0.022 CHEMBL1450936 | ||
| 0.188 | 0.101 | 0.778 | Angiogenesis stimulant | 0.134 0.133 CHEMBL1450936 0.778 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.098 | 0.011 | 0.098 | Phosphodiesterase 1C inhibitor | |||
| 0.132 | 0.046 | 0.132 | Falcipain 3 inhibitor | 0.115 0.057 CHEMBL1450936 | ||
| 0.118 | 0.031 | 0.118 | Histamine N-methyltransferase inhibitor | 0.09 0.056 CHEMBL1450936 | ||
| 0.113 | 0.027 | 0.113 | Bile acid receptor antagonist | 0.105 0.039 CHEMBL1450936 | ||
| 0.1 | 0.016 | 0.1 | Beta adrenoreceptor antagonist | 0.073 0.034 CHEMBL1450936 | ||
| 0.09 | 0.007 | 0.09 | Estrogen-related receptor alpha antagonist | 0.039 0.018 CHEMBL1450936 | ||
| 0.092 | 0.01 | 0.092 | Sphingosine kinase 2 inhibitor | 0.07 0.022 CHEMBL1450936 | ||
| 0.094 | 0.012 | 0.112 | Exportin-1 inhibitor | 0.112 0.005 CHEMBL1450936 | CHEMBL1450936 | |
| 0.134 | 0.053 | 0.187 | Protein-tyrosine phosphatase 1B inhibitor | 0.187 0.033 CHEMBL1450936 0.173 0.037 CHEMBL3544861 | CHEMBL1450936 | |
| 0.092 | 0.012 | 0.092 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 CHEMBL1450936 | ||
| 0.093 | 0.014 | 0.093 | Glutamate (mGluR6) antagonist | 0.08 0.025 CHEMBL1450936 | ||
| 0.093 | 0.013 | 0.093 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.043 CHEMBL1450936 | ||
| 0.125 | 0.045 | 0.243 | Xanthine oxidase inhibitor | 0.147 0.036 CHEMBL1450936 0.243 0.013 CHEMBL3544861 | CHEMBL3544861 | |
| 0.172 | 0.093 | 0.172 | Amyloid beta aggregation inhibitor | 0.157 0.103 CHEMBL1450936 0.157 0.103 CHEMBL3544861 | ||
| 0.138 | 0.059 | 0.138 | Cholinergic antagonist | |||
| 0.097 | 0.019 | 0.097 | Acetylcholine M3 receptor antagonist | |||
| 0.092 | 0.016 | 0.092 | Alpha tubulin antagonist | 0.08 0.02 CHEMBL1450936 | ||
| 0.134 | 0.059 | 0.134 | Acetylcholine antagonist | |||
| 0.082 | 0.008 | 0.107 | Glucose-6-phosphate isomerase inhibitor | 0.077 0.01 CHEMBL1450936 0.107 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.075 | 0.002 | 0.075 | Estrogen-related receptor gamma antagonist | 0.053 0.003 CHEMBL1450936 | ||
| 0.083 | 0.01 | 0.083 | Thromboxane synthase inhibitor | |||
| 0.08 | 0.008 | 0.08 | Retinoid X receptor agonist | 0.056 0.015 CHEMBL1450936 | ||
| 0.126 | 0.054 | 0.176 | Microtubule formation inhibitor | 0.176 0.027 CHEMBL1450936 0.155 0.035 CHEMBL3544861 | CHEMBL1450936 | |
| 0.085 | 0.013 | 0.085 | NMDA receptor subunit 3B antagonist | 0.056 0.021 CHEMBL1450936 | ||
| 0.118 | 0.047 | 0.126 | Urease inhibitor | 0.126 0.04 CHEMBL1450936 | CHEMBL1450936 | |
| 0.076 | 0.004 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.07 0.005 CHEMBL1450936 | ||
| 0.123 | 0.051 | 0.199 | MAO A inhibitor | 0.199 0.029 CHEMBL1450936 | CHEMBL1450936 | |
| 0.102 | 0.03 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.099 0.033 CHEMBL1450936 0.123 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.12 | 0.049 | 0.12 | Acetylcholine release stimulant | 0.1 0.088 CHEMBL1450936 0.115 0.057 CHEMBL3544861 | ||
| 0.081 | 0.009 | 0.081 | Squalene epoxidase inhibitor | 0.075 0.011 CHEMBL1450936 | ||
| 0.101 | 0.032 | 0.116 | Vanilloid agonist | 0.116 0.02 CHEMBL1450936 | CHEMBL1450936 | |
| 0.083 | 0.014 | 0.083 | Sphingosine kinase inhibitor | 0.063 0.034 CHEMBL1450936 | ||
| 0.145 | 0.077 | 0.358 | NOS3 expression enhancer | 0.255 0.025 CHEMBL1450936 0.358 0.011 CHEMBL3544861 | CHEMBL3544861 | |
| 0.109 | 0.042 | 0.109 | Alpha 2 adrenoreceptor antagonist | |||
| 0.115 | 0.048 | 0.185 | Toll-Like receptor 4 antagonist | 0.099 0.071 CHEMBL1450936 0.185 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.134 | 0.067 | 0.134 | NADPH oxidase inhibitor | 0.129 0.073 CHEMBL1450936 0.119 0.084 CHEMBL3544861 | ||
| 0.086 | 0.019 | 0.086 | Phosphodiesterase 1B inhibitor | |||
| 0.078 | 0.012 | 0.078 | NMDA receptor subunit 3A antagonist | 0.05 0.02 CHEMBL1450936 | ||
| 0.094 | 0.028 | 0.094 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.053 CHEMBL1450936 | ||
| 0.136 | 0.07 | 0.156 | Alkaline phosphatase inhibitor | 0.135 0.072 CHEMBL1450936 0.156 0.056 CHEMBL3544861 | CHEMBL3544861 | |
| 0.076 | 0.011 | 0.076 | Ryanodine receptor antagonist | 0.068 0.02 CHEMBL1450936 | ||
| 0.127 | 0.062 | 0.127 | Adenylate cyclase inhibitor | 0.105 0.079 CHEMBL1450936 | ||
| 0.07 | 0.005 | 0.07 | Estrone sulfatase inhibitor | |||
| 0.09 | 0.026 | 0.09 | Vanilloid 4 agonist | 0.077 0.046 CHEMBL1450936 | ||
| 0.106 | 0.042 | 0.153 | Phosphodiesterase 6D inhibitor | 0.11 0.036 CHEMBL1450936 0.153 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | 0.138 0.125 CHEMBL3544861 | ||
| 0.127 | 0.065 | 0.143 | M18 aspartyl aminopeptidase inhibitor | 0.143 0.055 CHEMBL1450936 | CHEMBL1450936 | |
| 0.13 | 0.069 | 0.191 | MAO inhibitor | 0.191 0.043 CHEMBL1450936 | CHEMBL1450936 | |
| 0.07 | 0.008 | 0.076 | Dopamine beta hydroxylase inhibitor | 0.076 0.006 CHEMBL1450936 | CHEMBL1450936 | |
| 0.135 | 0.074 | 0.135 | Nav1.6 sodium channel blocker | |||
| 0.086 | 0.025 | 0.101 | NMDA receptor agonist | 0.101 0.019 CHEMBL1450936 | CHEMBL1450936 | |
| 0.065 | 0.004 | 0.065 | 5 Hydroxytryptamine 1F agonist | |||
| 0.112 | 0.054 | 0.341 | Beta glucuronidase inhibitor | 0.126 0.04 CHEMBL1450936 0.341 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.103 | 0.045 | 0.103 | NMDA receptor antagonist | 0.081 0.065 CHEMBL1450936 | ||
| 0.071 | 0.013 | 0.071 | Leukotriene C antagonist | 0.063 0.022 CHEMBL1450936 | ||
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | 0.068 0.013 CHEMBL1450936 | ||
| 0.072 | 0.015 | 0.092 | Dihydroorotate oxidase inhibitor | 0.092 0.006 CHEMBL1450936 | CHEMBL1450936 | |
| 0.092 | 0.036 | 0.104 | Interferon agonist | 0.078 0.055 CHEMBL1450936 0.104 0.026 CHEMBL3544861 | CHEMBL3544861 | |
| 0.072 | 0.016 | 0.162 | Alpha-mannosidase inhibitor | 0.059 0.028 CHEMBL1450936 0.162 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.121 | 0.066 | 0.304 | Topoisomerase II inhibitor | 0.11 0.077 CHEMBL1450936 0.304 0.017 CHEMBL3544861 | CHEMBL3544861 | |
| 0.075 | 0.02 | 0.075 | Phosphodiesterase 1A inhibitor | |||
| 0.162 | 0.107 | 0.162 | I kappa B kinase epsilon inhibitor | 0.138 0.134 CHEMBL1450936 | ||
| 0.078 | 0.023 | 0.078 | Carbonic anhydrase VB inhibitor | 0.073 0.026 CHEMBL1450936 | ||
| 0.061 | 0.006 | 0.065 | Kainate receptor agonist | 0.065 0.005 CHEMBL1450936 | CHEMBL1450936 | |
| 0.069 | 0.015 | 0.069 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.024 CHEMBL1450936 | ||
| 0.094 | 0.041 | 0.096 | Adrenaline agonist | 0.096 0.04 CHEMBL1450936 | CHEMBL1450936 | |
| 0.084 | 0.031 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.035 CHEMBL1450936 | ||
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | 0.057 0.019 CHEMBL1450936 | ||
| 0.071 | 0.019 | 0.118 | Leukotriene B4 antagonist | 0.06 0.028 CHEMBL1450936 0.118 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.061 | 0.01 | 0.061 | GABA uptake inhibitor | 0.057 0.012 CHEMBL1450936 | ||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | 0.058 0.029 CHEMBL1450936 | ||
| 0.077 | 0.026 | 0.077 | Dopamine uptake inhibitor | |||
| 0.07 | 0.019 | 0.07 | Beta 2 adrenoreceptor agonist | 0.064 0.034 CHEMBL1450936 | ||
| 0.062 | 0.012 | 0.062 | Geranyltranstransferase inhibitor | 0.048 0.025 CHEMBL1450936 | ||
| 0.074 | 0.024 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 CHEMBL1450936 0.069 0.026 CHEMBL3544861 | CHEMBL1450936 | |
| 0.073 | 0.024 | 0.073 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CHEMBL1450936 | ||
| 0.057 | 0.009 | 0.057 | Leukotriene D4 antagonist | |||
| 0.063 | 0.015 | 0.063 | 5-Alpha-reductase inhibitor | 0.039 0.025 CHEMBL1450936 | ||
| 0.093 | 0.045 | 0.096 | Myeloperoxidase inhibitor | 0.096 0.039 CHEMBL1450936 | CHEMBL1450936 | |
| 0.078 | 0.03 | 0.078 | NMDA receptor glycine site agonist | 0.078 0.03 CHEMBL1450936 | ||
| 0.059 | 0.011 | 0.059 | Retinoid X alpha receptor agonist | 0.055 0.013 CHEMBL1450936 | ||
| 0.071 | 0.024 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.075 | 0.028 | 0.084 | Interferon inducer | 0.084 0.02 CHEMBL3544861 | CHEMBL3544861 | |
| 0.056 | 0.01 | 0.06 | Retinoic acid alpha receptor agonist | 0.06 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.145 | 0.1 | 0.146 | Antipruritic | 0.146 0.098 CHEMBL1450936 | CHEMBL1450936 | |
| 0.063 | 0.019 | 0.063 | Vanilloid 2 antagonist | 0.055 0.031 CHEMBL1450936 | ||
| 0.051 | 0.007 | 0.051 | ATP citrate lysase inhibitor | 0.039 0.014 CHEMBL1450936 | ||
| 0.068 | 0.025 | 0.068 | Phosphodiesterase 4A inhibitor | |||
| 0.08 | 0.037 | 0.08 | Carbonic anhydrase VA inhibitor | 0.078 0.038 CHEMBL1450936 | ||
| 0.112 | 0.069 | 0.112 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.06 | 0.017 | 0.165 | Mannosidase inhibitor | 0.047 0.029 CHEMBL1450936 0.165 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.056 | 0.013 | 0.056 | Kainate receptor 2 antagonist | 0.036 0.025 CHEMBL1450936 | ||
| 0.063 | 0.021 | 0.063 | Beta 2 adrenoreceptor antagonist | 0.054 0.031 CHEMBL1450936 | ||
| 0.053 | 0.01 | 0.054 | Retinoid X receptor antagonist | 0.054 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.148 | 0.106 | 0.274 | DNA methyltransferase I inhibitor | 0.192 0.073 CHEMBL1450936 0.274 0.037 CHEMBL3544861 | CHEMBL3544861 | |
| 0.052 | 0.01 | 0.052 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.045 0.013 CHEMBL1450936 | ||
| 0.083 | 0.041 | 0.083 | Cathepsin G inhibitor | |||
| 0.054 | 0.012 | 0.056 | Fumarate hydratase inhibitor | 0.056 0.011 CHEMBL1450936 0.031 0.028 CHEMBL3544861 | CHEMBL1450936 | |
| 0.113 | 0.071 | 0.118 | Interleukin 8 antagonist | 0.118 0.064 CHEMBL1450936 | CHEMBL1450936 | |
| 0.12 | 0.079 | 0.211 | Tubulin antagonist | 0.211 0.034 CHEMBL1450936 | CHEMBL1450936 | |
| 0.059 | 0.018 | 0.076 | Factor III inhibitor | 0.076 0.009 CHEMBL1450936 0.067 0.012 CHEMBL3544861 | CHEMBL1450936 | |
| 0.051 | 0.011 | 0.051 | Glutamate (mGluR8) agonist | 0.046 0.015 CHEMBL1450936 | ||
| 0.043 | 0.004 | 0.067 | Vanilloid 2 agonist | 0.032 0.008 CHEMBL1450936 0.067 0.002 CHEMBL3544861 | CHEMBL3544861 | |
| 0.052 | 0.014 | 0.052 | Nicotinic acid receptor agonist | 0.046 0.017 CHEMBL1450936 | ||
| 0.053 | 0.014 | 0.053 | Glucocorticoid antagonist | |||
| 0.053 | 0.014 | 0.053 | Alpha 1d adrenoreceptor agonist | 0.044 0.022 CHEMBL1450936 | ||
| 0.071 | 0.033 | 0.071 | Adenosine A1 receptor antagonist | |||
| 0.069 | 0.031 | 0.075 | Transcription factor RelA inhibitor | 0.075 0.023 CHEMBL1450936 | CHEMBL1450936 | |
| 0.076 | 0.038 | 0.076 | Carbonic anhydrase V inhibitor | 0.074 0.039 CHEMBL1450936 | ||
| 0.054 | 0.017 | 0.057 | Guanylate cyclase inhibitor | 0.049 0.022 CHEMBL1450936 0.057 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.098 | 0.061 | 0.111 | MAO B inhibitor | 0.111 0.055 CHEMBL1450936 | CHEMBL1450936 | |
| 0.068 | 0.03 | 0.068 | Heat shock protein 90 beta antagonist | 0.055 0.048 CHEMBL1450936 | ||
| 0.088 | 0.051 | 0.088 | mTOR complex 2 inhibitor | 0.082 0.063 CHEMBL1450936 | ||
| 0.058 | 0.022 | 0.058 | Potassium channel Kv1.3 blocker | 0.058 0.022 CHEMBL1450936 | ||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.049 0.032 CHEMBL3544861 | ||
| 0.062 | 0.025 | 0.079 | Adenine nucleotide translocase inhibitor | 0.057 0.035 CHEMBL1450936 0.079 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.043 | 0.007 | 0.043 | Glutamate (mGluR3) agonist | 0.037 0.013 CHEMBL1450936 | ||
| 0.045 | 0.01 | 0.047 | Uridine phosphorylase inhibitor | 0.036 0.014 CHEMBL1450936 0.047 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.047 | 0.013 | 0.047 | Leukotriene C4 antagonist | 0.041 0.021 CHEMBL1450936 | ||
| 0.056 | 0.022 | 0.056 | Estradiol 17 beta-dehydrogenase inhibitor | 0.054 0.023 CHEMBL1450936 | ||
| 0.094 | 0.06 | 0.094 | Potassium channel (Ca-activated) activator | 0.088 0.067 CHEMBL1450936 | ||
| 0.07 | 0.036 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.029 CHEMBL1450936 | CHEMBL1450936 | |
| 0.067 | 0.033 | 0.067 | Xanthine dehydrogenase inhibitor | 0.066 0.034 CHEMBL1450936 | ||
| 0.11 | 0.076 | 0.11 | Caspase 3 inhibitor | 0.105 0.083 CHEMBL1450936 | ||
| 0.067 | 0.034 | 0.067 | Calcium channel P-type blocker | |||
| 0.05 | 0.017 | 0.05 | Sphingosine kinase 1 inhibitor | |||
| 0.044 | 0.011 | 0.045 | Retinoid X alpha receptor antagonist | 0.045 0.01 CHEMBL1450936 | CHEMBL1450936 | |
| 0.064 | 0.031 | 0.067 | Fatty acid synthase inhibitor | 0.067 0.028 CHEMBL1450936 | CHEMBL1450936 | |
| 0.132 | 0.1 | 0.132 | Sigma receptor agonist | |||
| 0.067 | 0.036 | 0.067 | NMDA 2C receptor antagonist | |||
| 0.048 | 0.017 | 0.055 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.055 0.013 CHEMBL1450936 | CHEMBL1450936 | |
| 0.049 | 0.018 | 0.049 | Dihydropteroate synthase inhibitor | 0.041 0.025 CHEMBL1450936 | ||
| 0.057 | 0.027 | 0.11 | Carbonic anhydrase XIV inhibitor | 0.047 0.037 CHEMBL1450936 0.11 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.045 | 0.015 | 0.045 | Delayed rectifier potassium channel blocker | |||
| 0.056 | 0.026 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.034 | 0.004 | 0.034 | Nicotinic acid receptor 1 antagonist | 0.024 0.006 CHEMBL1450936 | ||
| 0.129 | 0.101 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.035 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 CHEMBL1450936 | CHEMBL1450936 | |
| 0.05 | 0.022 | 0.05 | Kainate receptor antagonist | 0.035 0.034 CHEMBL1450936 | ||
| 0.099 | 0.071 | 0.259 | Mediator release inhibitor | 0.259 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.034 | 0.007 | 0.034 | Leukotriene B4 receptor 2 antagonist | 0.03 0.009 CHEMBL1450936 0.031 0.008 CHEMBL3544861 | ||
| 0.094 | 0.066 | 0.094 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.066 | 0.039 | 0.066 | Adrenaline uptake inhibitor | |||
| 0.043 | 0.016 | 0.043 | Vanilloid 3 antagonist | 0.038 0.027 CHEMBL1450936 | ||
| 0.101 | 0.075 | 0.101 | Chelator | |||
| 0.065 | 0.04 | 0.065 | Adenosine A2a receptor antagonist | |||
| 0.033 | 0.008 | 0.033 | Hedgehog signaling activator | 0.027 0.019 CHEMBL1450936 | ||
| 0.058 | 0.033 | 0.058 | Glucosylceramidase inhibitor | |||
| 0.029 | 0.004 | 0.047 | Antibiotic Anthracycline-like | 0.024 0.006 CHEMBL1450936 0.047 0.002 CHEMBL3544861 | CHEMBL3544861 | |
| 0.141 | 0.117 | 0.145 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.109 CHEMBL1450936 | CHEMBL1450936 | |
| 0.038 | 0.014 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.026 CHEMBL1450936 | ||
| 0.051 | 0.027 | 0.058 | Cytokine production stimulant | 0.058 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.032 | 0.009 | 0.032 | Retinoic acid receptor agonist | 0.023 0.016 CHEMBL1450936 | ||
| 0.033 | 0.01 | 0.033 | Thyroid hormone agonist | 0.026 0.018 CHEMBL1450936 | ||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.031 | 0.008 | 0.031 | Prostaglandin F2 alpha agonist | 0.026 0.012 CHEMBL1450936 | ||
| 0.083 | 0.06 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.062 | 0.04 | 0.062 | Acetylcholine M5 receptor antagonist | |||
| 0.029 | 0.007 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 CHEMBL1450936 | CHEMBL1450936 | |
| 0.041 | 0.019 | 0.041 | Phosphoglycerate kinase inhibitor | 0.033 0.027 CHEMBL1450936 | ||
| 0.055 | 0.033 | 0.055 | NMDA 2A receptor antagonist | |||
| 0.027 | 0.005 | 0.071 | Ileal bile acid transport inhibitor | 0.071 0.003 CHEMBL3544861 | CHEMBL3544861 | |
| 0.03 | 0.008 | 0.03 | Retinoid X beta receptor agonist | |||
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | 0.051 0.031 CHEMBL1450936 0.045 0.042 CHEMBL3544861 | ||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | 0.028 0.022 CHEMBL1450936 | ||
| 0.156 | 0.135 | 0.167 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.167 0.124 CHEMBL1450936 | CHEMBL1450936 | |
| 0.063 | 0.042 | 0.063 | Dopamine D3 antagonist | |||
| 0.027 | 0.006 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.026 0.006 CHEMBL1450936 | ||
| 0.032 | 0.012 | 0.117 | Sodium/glucose cotransporter 2 inhibitor | 0.039 0.009 CHEMBL1450936 0.117 0.002 CHEMBL3544861 | CHEMBL3544861 | |
| 0.06 | 0.04 | 0.06 | Carbonic anhydrase stimulant | |||
| 0.035 | 0.015 | 0.035 | Liver X receptor beta antagonist | |||
| 0.056 | 0.036 | 0.056 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.057 | 0.038 | 0.057 | Ribonucleotide reductase inhibitor | |||
| 0.046 | 0.027 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.025 CHEMBL1450936 | CHEMBL1450936 | |
| 0.026 | 0.006 | 0.027 | Retinoid X beta receptor antagonist | 0.027 0.005 CHEMBL1450936 | CHEMBL1450936 | |
| 0.073 | 0.054 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.037 | 0.019 | 0.037 | Free fatty acid receptor 1 antagonist | |||
| 0.051 | 0.033 | 0.051 | CD45 antagonist | 0.048 0.041 CHEMBL1450936 | ||
| 0.029 | 0.012 | 0.114 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CHEMBL1450936 0.114 0.002 CHEMBL3544861 | CHEMBL3544861 | |
| 0.033 | 0.016 | 0.033 | Leukotriene B4 receptor 1 antagonist | 0.024 0.022 CHEMBL1450936 0.026 0.021 CHEMBL3544861 | ||
| 0.042 | 0.024 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.066 | 0.048 | 0.066 | Potassium channel (ATP-sensitive) blocker | |||
| 0.062 | 0.045 | 0.077 | HIV-1 integrase (3'-Processing) inhibitor | 0.077 0.035 CHEMBL1450936 0.057 0.051 CHEMBL3544861 | CHEMBL1450936 | |
| 0.026 | 0.009 | 0.026 | Vitamin D receptor antagonist | 0.023 0.014 CHEMBL3544861 | ||
| 0.026 | 0.01 | 0.026 | 5-Alpha-reductase 2 inhibitor | |||
| 0.053 | 0.037 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.022 | 0.005 | 0.022 | Vitamin D receptor agonist | 0.018 0.009 CHEMBL1450936 0.018 0.009 CHEMBL3544861 | ||
| 0.048 | 0.032 | 0.048 | Glycine transporter 2 inhibitor | |||
| 0.022 | 0.006 | 0.03 | Telomerase stimulant | 0.02 0.008 CHEMBL1450936 0.03 0.003 CHEMBL3544861 | CHEMBL3544861 | |
| 0.039 | 0.023 | 0.073 | Arginase inhibitor | 0.073 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.037 | 0.021 | 0.037 | Ceramide glucosyltransferase inhibitor | |||
| 0.028 | 0.013 | 0.028 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.025 0.014 CHEMBL1450936 | ||
| 0.024 | 0.009 | 0.024 | Retinoic acid beta receptor agonist | 0.023 0.009 CHEMBL1450936 | ||
| 0.057 | 0.042 | 0.057 | Plasminogen activator inhibitor | |||
| 0.039 | 0.024 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.138 | 0.123 | 0.485 | Hepatoprotectant | 0.195 0.068 CHEMBL1450936 0.485 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.071 | 0.056 | 0.071 | CDC25A inhibitor | |||
| 0.074 | 0.059 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CHEMBL1450936 | ||
| 0.06 | 0.046 | 0.065 | Heme oxygenase stimulant | 0.065 0.033 CHEMBL1450936 | CHEMBL1450936 | |
| 0.057 | 0.043 | 0.072 | Lipocortins synthesis agonist | 0.056 0.046 CHEMBL1450936 0.072 0.019 CHEMBL3544861 | CHEMBL3544861 | |
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CHEMBL1450936 | ||
| 0.043 | 0.029 | 0.043 | Heme oxygenase inhibitor | |||
| 0.037 | 0.024 | 0.037 | Progesterone antagonist | |||
| 0.023 | 0.01 | 0.023 | 5-Alpha-reductase 1 inhibitor | |||
| 0.041 | 0.028 | 0.041 | Liver X receptor alpha agonist | |||
| 0.087 | 0.075 | 0.088 | MAP kinase kinase 1 inhibitor | 0.088 0.072 CHEMBL1450936 | CHEMBL1450936 | |
| 0.054 | 0.042 | 0.054 | 5 Hydroxytryptamine 7 agonist | |||
| 0.025 | 0.013 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.127 | 0.115 | 0.127 | Heat shock protein 90 alpha antagonist | |||
| 0.016 | 0.005 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 CHEMBL1450936 | ||
| 0.085 | 0.074 | 0.085 | Protein kinase C zeta inhibitor | |||
| 0.039 | 0.028 | 0.043 | Membrane dipeptidase inhibitor | 0.043 0.023 CHEMBL1450936 | CHEMBL1450936 | |
| 0.024 | 0.013 | 0.024 | Kainate receptor 1 antagonist | |||
| 0.118 | 0.107 | 0.247 | Diuretic | 0.118 0.107 CHEMBL1450936 0.247 0.031 CHEMBL3544861 | CHEMBL3544861 | |
| 0.039 | 0.03 | 0.045 | CF transmembrane conductance regulator antagonist | 0.045 0.015 CHEMBL1450936 | CHEMBL1450936 | |
| 0.072 | 0.062 | 0.072 | Somatostatin 1 agonist | |||
| 0.052 | 0.043 | 0.052 | Epithelial sodium channel blocker | |||
| 0.017 | 0.009 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.018 0.008 CHEMBL1450936 | CHEMBL1450936 | |
| 0.032 | 0.024 | 0.032 | Catechol O-methyltransferase inhibitor | 0.03 0.027 CHEMBL1450936 | ||
| 0.098 | 0.09 | 0.213 | Alkylator | 0.104 0.084 CHEMBL1450936 0.213 0.023 CHEMBL3544861 | CHEMBL3544861 | |
| 0.036 | 0.028 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 CHEMBL1450936 | CHEMBL1450936 | |
| 0.042 | 0.034 | 0.042 | AICAR transformylase inhibitor | |||
| 0.056 | 0.049 | 0.058 | TRPA1 antagonist | 0.058 0.047 CHEMBL1450936 | CHEMBL1450936 | |
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.091 | 0.084 | 0.301 | AMP-activated protein kinase stimulant | 0.091 0.084 CHEMBL1450936 0.301 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.04 | 0.034 | 0.04 | Angiotensin AT1 receptor antagonist | |||
| 0.059 | 0.053 | 0.059 | CDC25B inhibitor | |||
| 0.094 | 0.088 | 0.094 | Protein kinase C gamma inhibitor | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.06 | 0.054 | 0.06 | Prolactin release inhibitor | |||
| 0.136 | 0.131 | 0.268 | DNA methylase inhibitor | 0.181 0.093 CHEMBL1450936 0.268 0.039 CHEMBL3544861 | CHEMBL3544861 | |
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CHEMBL1450936 | ||
| 0.043 | 0.038 | 0.043 | Purinergic P2X4 antagonist | |||
| 0.057 | 0.052 | 0.057 | Adenosine A2 receptor antagonist | |||
| 0.025 | 0.02 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.014 CHEMBL1450936 | CHEMBL1450936 | |
| 0.017 | 0.012 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.017 | 0.012 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.108 | 0.103 | 0.195 | DNA repair enzyme inhibitor | 0.195 0.01 CHEMBL3544861 | CHEMBL3544861 | |
| 0.025 | 0.021 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.05 | 0.046 | 0.05 | Lysine-specific demethylase 1A inhibitor | |||
| 0.031 | 0.028 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.058 | 0.055 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.053 | 0.05 | 0.053 | Botulinum neurotoxin type A inhibitor | |||
| 0.051 | 0.048 | 0.051 | Alpha 1d adrenoreceptor antagonist | |||
| 0.092 | 0.089 | 0.092 | Nav1.4 sodium channel blocker | |||
| 0.044 | 0.041 | 0.044 | Cholesterol esterase inhibitor | |||
| 0.064 | 0.061 | 0.064 | MDM2 inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.119 | 0.117 | 0.119 | Heat shock protein 90 antagonist | |||
| 0.028 | 0.026 | 0.028 | Prostaglandin agonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.046 | 0.045 | 0.046 | Potassium channel (Inward rectifier) activator | |||
| 0.048 | 0.049 | 0.147 | Heparanase inhibitor | 0.147 0.003 CHEMBL3544861 | CHEMBL3544861 | |
| 0.048 | 0.052 | 0.057 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.043 CHEMBL1450936 | CHEMBL1450936 | |
| 0.024 | 0.028 | 0.029 | Retinoid X gamma receptor antagonist | 0.029 0.014 CHEMBL1450936 | CHEMBL1450936 | |
| 0.057 | 0.061 | 0.125 | Neuraminidase (influenza) inhibitor | 0.068 0.037 CHEMBL1450936 0.125 0.011 CHEMBL3544861 | CHEMBL3544861 | |
| 0.119 | 0.124 | 0.154 | CC chemokine 6 receptor antagonist | 0.133 0.06 CHEMBL1450936 0.154 0.018 CHEMBL3544861 | CHEMBL3544861 | |
| 0.019 | 0.025 | 0.03 | Dopamine D1 agonist | 0.03 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.025 | 0.031 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.016 | 0.022 | 0.023 | Retinoic acid alpha receptor antagonist | 0.023 0.011 CHEMBL1450936 | CHEMBL1450936 | |
| 0.136 | 0.144 | 0.149 | Catenin beta inhibitor | 0.149 0.109 CHEMBL1450936 | CHEMBL1450936 | |
| 0.014 | 0.022 | 0.019 | Retinoic acid receptor antagonist | 0.019 0.012 CHEMBL1450936 | CHEMBL1450936 | |
| 0.044 | 0.053 | 0.107 | Glucose-6-phosphate translocase inhibitor | 0.048 0.043 CHEMBL1450936 0.107 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.065 | 0.077 | 0.07 | Phosphodiesterase VI inhibitor | 0.07 0.061 CHEMBL3544861 | CHEMBL3544861 | |
| 0.187 | 0.199 | 0.477 | Apoptosis antagonist | 0.416 0.034 CHEMBL1450936 0.477 0.023 CHEMBL3544861 | CHEMBL3544861 | |
| 0.007 | 0.02 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.179 | 0.194 | 0.202 | MAP kinase kinase 3 inhibitor | 0.202 0.116 CHEMBL1450936 | CHEMBL1450936 | |
| 0.081 | 0.097 | 0.13 | Interleukin 12 antagonist | 0.13 0.021 CHEMBL3544861 | CHEMBL3544861 | |
| 0.052 | 0.069 | 0.106 | Leukotriene synthesis inhibitor | 0.106 0.023 CHEMBL1450936 | CHEMBL1450936 | |
| 0.14 | 0.16 | 0.242 | Antiamyloidogenic | 0.242 0.074 CHEMBL3544861 | CHEMBL3544861 | |
| 0.038 | 0.058 | 0.125 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 CHEMBL1450936 0.125 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.044 | 0.066 | 0.107 | Neuraminidase inhibitor | 0.062 0.041 CHEMBL1450936 0.107 0.013 CHEMBL3544861 | CHEMBL3544861 | |
| 0.035 | 0.058 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CHEMBL3544861 | CHEMBL3544861 | |
| 0.012 | 0.045 | 0.02 | Corticosteroid-like | 0.02 0.017 CHEMBL3544861 | CHEMBL3544861 | |
| 0.069 | 0.105 | 0.085 | Interleukin 5 antagonist | 0.085 0.063 CHEMBL3544861 | CHEMBL3544861 | |
| 0.046 | 0.082 | 0.06 | 5 Hydroxytryptamine 3 agonist | 0.06 0.048 CHEMBL1450936 | CHEMBL1450936 | |
| 0.052 | 0.089 | 0.188 | Topoisomerase II alpha inhibitor | 0.084 0.05 CHEMBL1450936 0.188 0.017 CHEMBL3544861 | CHEMBL3544861 | |
| 0.069 | 0.108 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 CHEMBL1450936 0.128 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.114 | 0.154 | 0.13 | Amyloid beta precursor protein antagonist | 0.13 0.126 CHEMBL1450936 | CHEMBL1450936 | |
| 0.053 | 0.094 | 0.071 | HIV-1 integrase inhibitor | 0.071 0.047 CHEMBL1450936 | CHEMBL1450936 | |
| 0.068 | 0.11 | 0.089 | Thioredoxin reductase inhibitor | 0.089 0.043 CHEMBL1450936 | CHEMBL1450936 | |
| 0.044 | 0.092 | 0.229 | Antineoplastic antibiotic | 0.182 0.024 CHEMBL1450936 0.229 0.017 CHEMBL3544861 | CHEMBL3544861 | |
| 0.011 | 0.059 | 0.047 | Squalene synthetase inhibitor | 0.047 0.015 CHEMBL3544861 | CHEMBL3544861 | |
| 0.066 | 0.117 | 0.16 | Transcription factor NF kappa B stimulant | 0.16 0.014 CHEMBL3544861 | CHEMBL3544861 | |
| 0.003 | 0.055 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 CHEMBL3544861 | CHEMBL3544861 | |
| 0.042 | 0.096 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.044 CHEMBL3544861 | CHEMBL3544861 | |
| 0.04 | 0.094 | 0.086 | Acetyl-CoA transferase 2 inhibitor | 0.086 0.009 CHEMBL1450936 | CHEMBL1450936 | |
| 0.062 | 0.13 | 0.133 | Uric acid excretion stimulant | 0.094 0.059 CHEMBL1450936 0.133 0.03 CHEMBL3544861 | CHEMBL3544861 | |
| 0.106 | 0.177 | 0.2 | Interleukin antagonist | 0.2 0.084 CHEMBL1450936 | CHEMBL1450936 | |
| 0.17 | 0.244 | 0.475 | Alpha-glucosidase inhibitor | 0.475 0.088 CHEMBL3544861 | CHEMBL3544861 | |
| 0.012 | 0.089 | 0.063 | Protein 30S ribosomal subunit inhibitor | 0.063 0.005 CHEMBL3544861 | CHEMBL3544861 | |
| 0.019 | 0.1 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 CHEMBL3544861 | CHEMBL3544861 | |
| 0.022 | 0.104 | 0.082 | Antibiotic Aminoglycoside-like | 0.082 0.004 CHEMBL3544861 | CHEMBL3544861 | |
| 0.029 | 0.112 | 0.389 | Selectin antagonist | 0.389 0.003 CHEMBL3544861 | CHEMBL3544861 | |
| 0.02 | 0.112 | 0.074 | Aldose reductase inhibitor | 0.074 0.025 CHEMBL3544861 | CHEMBL3544861 | |
| 0.095 | 0.188 | 0.362 | Hemostatic | 0.362 0.01 CHEMBL3544861 | CHEMBL3544861 | |
| 0.03 | 0.126 | 0.076 | Nitric oxide donor | 0.076 0.026 CHEMBL3544861 | CHEMBL3544861 | |
| 0.048 | 0.148 | 0.239 | Topoisomerase I inhibitor | 0.239 0.018 CHEMBL3544861 | CHEMBL3544861 | |
| 0.016 | 0.146 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CHEMBL3544861 | CHEMBL3544861 | |
| 0.092 | 0.226 | 0.309 | Hypolipemic | 0.309 0.046 CHEMBL3544861 | CHEMBL3544861 | |
| 0.021 | 0.158 | 0.047 | Microtubule stabilization | 0.047 0.031 CHEMBL3544861 | CHEMBL3544861 | |
| 0.012 | 0.177 | 0.039 | Cyclophilin A inhibitor | 0.039 0.012 CHEMBL1450936 | CHEMBL1450936 | |
| 0.002 | 0.169 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 CHEMBL1450936 | CHEMBL1450936 | |
| 0.029 | 0.24 | 0.096 | Histone deacetylase SIRT1 stimulant | 0.096 0.03 CHEMBL3544861 | CHEMBL3544861 | |
| 0.029 | 0.24 | 0.096 | Histone deacetylase stimulant | 0.096 0.03 CHEMBL3544861 | CHEMBL3544861 | |
| 0.072 | 0.29 | 0.269 | Insulin secretagoues | 0.269 0.016 CHEMBL3544861 | CHEMBL3544861 | |
| 0.14 | 0.379 | 0.778 | Cyclophilin D inhibitor | 0.778 0.008 CHEMBL3544861 | CHEMBL3544861 | |
| 0.065 | 0.307 | 0.403 | Platelet adhesion inhibitor | 0.403 0.011 CHEMBL3544861 | CHEMBL3544861 | |
| 0.036 | 0.329 | 0.086 | Falcipain inhibitor | 0.086 0.067 CHEMBL3544861 | CHEMBL3544861 | |
| 0.035 | 0.332 | 0.083 | Falcipain 2 inhibitor | 0.083 0.066 CHEMBL3544861 | CHEMBL3544861 | |
| 0.026 | 0.327 | 0.116 | DNA intercalator | 0.116 0.06 CHEMBL3544861 | CHEMBL3544861 | |
| 0.026 | 0.404 | 0.094 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.09 CHEMBL3544861 | CHEMBL3544861 | |
| 0.031 | 0.479 | 0.281 | Platelet antagonist | 0.281 0.059 CHEMBL3544861 | CHEMBL3544861 | |
| 0.017 | 0.466 | 0.087 | Factor IXa inhibitor | 0.087 0.014 CHEMBL3544861 | CHEMBL3544861 | |
| 0.021 | 0.524 | 0.23 | Anticoagulant | 0.23 0.044 CHEMBL3544861 | CHEMBL3544861 | |
| 0.026 | 0.544 | 0.099 | Interleukin 1b antagonist | 0.099 0.082 CHEMBL1450936 | CHEMBL1450936 | |
| 0.022 | 0.573 | 0.231 | Cell adhesion inhibitor | 0.231 0.018 CHEMBL3544861 | CHEMBL3544861 | |
| 0.067 | 0.624 | 0.732 | Antiinflammatory | 0.423 0.125 CHEMBL1450936 0.732 0.025 CHEMBL3544861 | CHEMBL3544861 | |
| 0.031 | 0.589 | 0.082 | T cell inhibitor | 0.082 0.058 CHEMBL3544861 | CHEMBL3544861 | |
| 0.011 | 0.598 | 0.111 | Cell adhesion molecule inhibitor | 0.111 0.028 CHEMBL3544861 | CHEMBL3544861 | |
| 0.025 | 0.631 | 0.363 | Tumour necrosis factor alpha release inhibitor | 0.363 0.035 CHEMBL3544861 | CHEMBL3544861 | |
| 0.017 | 0.823 | 0.34 | Immunomodulator | 0.34 0.063 CHEMBL3544861 | CHEMBL3544861 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |